Moreover, endometrial carcinoma patients with lymph node metastasis presented notably higher CKS2 expression than endometrial carcinoma patients without lymph node metastasis (p < 0.001) (Supplementary Figure S2) (Table 3). This evidence concerns the gene CKS2 and metastatic malignant neoplasm in the lymph nodes.